Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
280,5 TWD | -0,71 % | -3,77 % | +3,12 % |
Resumen de negocios
Número de empleados: 1 099
Ventas por actividad
TWD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
99,4
%
| 14 503 | 99,1 % | 16 864 | 99,4 % | +16,28 % |
Other
0,6
%
| 130 | 0,9 % | 94 | 0,6 % | -27,72 % |
Ventas por región
TWD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
40,2
%
| 5 916 | 40,4 % | 6 815 | 40,2 % | +15,18 % |
South Korea
32,9
%
| 5 277 | 36,1 % | 5 587 | 32,9 % | +5,86 % |
Taiwan
14,2
%
| 1 439 | 9,8 % | 2 413 | 14,2 % | +67,67 % |
Others
12,6
%
| 2 000 | 13,7 % | 2 144 | 12,6 % | +7,18 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 29/09/14 | |
I ling Tian
DFI | Director of Finance/CFO | - | 01/11/16 |
Ying Ming Yue
COO | Chief Operating Officer | - | 01/12/22 |
Gwen Hsieh
CIO | Chief Investment Officer | - | 02/08/21 |
Manisha Chawla
CTO | Chief Tech/Sci/R&D Officer | - | 08/07/19 |
Edin Buljubašic
CMP | Compliance Officer | - | 01/12/22 |
Erica Yen
IRC | Investor Relations Contact | - | - |
Bjartur Shen
IRO | Public Communications Contact | - | 16/01/18 |
Ryan Koh
AUD | Comptroller/Controller/Auditor | - | 10/11/22 |
Prashant Godse
PRN | Corporate Officer/Principal | - | 01/03/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Vilhelm Wessman
CHM | Chairman | 54 | 23/04/15 |
Director/Board Member | 60 | 11/08/14 | |
Director/Board Member | 61 | 23/04/15 | |
Han Fei Lin
BRD | Director/Board Member | - | 27/06/16 |
Árni Harðarson
BRD | Director/Board Member | 57 | 11/08/14 |
Chief Executive Officer | - | 29/09/14 | |
Mu Yao Ku
BRD | Director/Board Member | - | 29/09/14 |
Yves Hermes
BRD | Director/Board Member | - | 30/06/22 |
Director/Board Member | - | 30/06/22 | |
Director/Board Member | - | 30/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 264 958 300 | 128 414 312 ( 48,47 %) | 490 000 ( 0,1849 %) | 48,47 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
FUJI PHARMA CO., LTD. 4.92% | 1 219 000 | 4.92% | 12 316 654 $ |
Información de la empresa
Lotus Pharmaceutical Co., Ltd.
No. 277, Song Ren Road 17/F, Xin Yi District
110 58, Taipei
+
http://www.lotuspharm.comVentas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+3,12 % | 2321,05 M | |
+38,59 % | 727 mil M | |
-7,89 % | 354 mil M | |
+15,66 % | 328 mil M | |
+0,24 % | 277 mil M | |
+13,47 % | 243 mil M | |
+7,35 % | 205 mil M | |
-6,42 % | 203 mil M | |
+4,23 % | 164 mil M | |
-1,70 % | 164 mil M |
- Bolsa de valores
- Acciones
- Acción 1795
- Empresa Lotus Pharmaceutical Co., Ltd.